Lewes, DE -- (SBWIRE) -- 08/20/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: North American Oil & Gas Corp (OTCBB:NAMG), Affymax, Inc. (OTCMKTS:AFFY), SafeStitch Medical Inc (OTCBB:SFES), AMARANTUS BIOSCIENCE HOLDINGS, INC. (OTCBB:AMBS).
North American Oil & Gas Corp (OTCBB:NAMG) ended higher +6.35% and complete the day at $1.34. The total number of shares changed hands during the day was 330,263. After opening at $1.26, the stock hit as high as $1.36. However, it traded between $0.25 and $1.67 over the last twelve months.
North American Oil & Gas Corp., formerly Calendar Dragon Inc., is a development-stage company. The Company was formed to create a new calendaring tool that incorporates a range of features not offered by other providers, all in one lean online package.
For How Long NAMG will Fight for Profitability? Read This Trend Analysis report
Affymax, Inc. (OTCMKTS:AFFY) closed yesterday at $1.60, a +1.27% increase. Around 384,166 shares were traded, low from an-average trading volume of 1.14 million shares. The company is now valued at around $59.98 million.
Affymax, Inc. is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, peginesatide, is for the treatment of anemia in chronic kidney disease patients on dialysis.
For How Long AFFY Gloss will Attract Investors? Find out via this report
SafeStitch Medical Inc (OTCBB:SFES) moved +29.55 percent higher at $1.14 and traded between $0.90 and $1.19 after opening the day at $0.90. Its performance over the last five days remained 32.56%, which stands at 119.23% for a month. Going back further than one month, 1-year performance after recent close was 418.18%.
SafeStitch Medical, Inc. (SafeStitch) is a developmental stage medical device company focused on the development of medical devices that manipulate tissues for the treatment of hernia formation, obesity, gastroesophageal reflux disease (GERD), esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery
For How Long SFES Gloss will Attract Investors? Find out via this report
AMARANTUS BIOSCIENCE HOLDINGS, INC. (OTCBB:AMBS) shares rose, gaining +3.16 percent to close at $0.0344. Around 7.33 million shares changed hands yesterday.
Amarantus BioScience Holdings, Inc., a development-stage biotechnology company, focuses on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases in the United States.
Why Should Investors Buy AMBS After The Recent Gain? Just Go Here and Find Out
About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/